Elafibranor, an Agonist of the Peroxisome Proliferator−Activated Receptor−α and −δ, Induces Resolution of Nonalcoholic Steatohepatitis Without Fibrosis WorseningVlad Ratziu, Juan F. Gallegos‐Orozco, Velimir A. Luketic et al.|Gastroenterology|2016Cited by 1k
JNJ-56136379, an HBV Capsid Assembly Modulator, Is Well-Tolerated and Has Antiviral Activity in a Phase 1 Study of Patients With Chronic InfectionFabien Zoulim, Jeysen Yogaratnam, Oliver Lenz et al.|Gastroenterology|2020Cited by 116
Hepatocellular carcinoma recurrence after direct-acting antiviral therapy: an individual patient data meta-analysisVíctor Sapena, María Reig, Marco Enea et al.|Gut|2021Cited by 96
Range of Normal Liver Stiffness and Factors Associated With Increased Stiffness Measurements in Apparently Healthy IndividualsFateh Bazerbachi, Kymberly D. Watt, Samir Haffar et al.|Clinical Gastroenterology and Hepatology|2018Cited by 80
Hepatitis D double reflex testing of all hepatitis B carriers in low-HBV- and high-HBV/HDV-prevalence countriesHomie Razavi, Ching‐Chih Hu, Marı́a Buti et al.|Journal of Hepatology|2023Cited by 61